Oragenics, Inc. (LON: 0A64)

Oragenics Statistics

Total Valuation

Oragenics has a market cap or net worth of GBP 3.04 million. The enterprise value is 2.21 million.

Market Cap	3.04M
Enterprise Value	2.21M

Important Dates

The next estimated earnings date is Monday, March 24, 2025.

Earnings Date	Mar 24, 2025
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	n/a
Shares Outstanding	n/a
Shares Change (YoY)	+99.08%
Shares Change (QoQ)	+44.14%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	9.05M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
PB Ratio	n/a
P/TBV Ratio	2.74
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-0.15
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 1.93, with a Debt / Equity ratio of 0.17.

Current Ratio	1.93
Quick Ratio	1.48
Debt / Equity	0.17
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-643.29

Financial Efficiency

Return on equity (ROE) is -417.05% and return on invested capital (ROIC) is -235.58%.

Return on Equity (ROE)	-417.05%
Return on Assets (ROA)	-190.79%
Return on Invested Capital (ROIC)	-235.58%
Return on Capital Employed (ROCE)	-649.85%
Revenue Per Employee	n/a
Profits Per Employee	-2.98M
Employee Count	5
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -92.22% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-92.22%
50-Day Moving Average	0.33
200-Day Moving Average	1.62
Relative Strength Index (RSI)	43.87
Average Volume (20 Days)	3,232

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	1.57

Income Statement

Revenue	n/a
Gross Profit	-10.07M
Operating Income	-14.92M
Pretax Income	-14.90M
Net Income	-14.90M
EBITDA	-14.91M
EBIT	-14.92M
Earnings Per Share (EPS)	-3.47

Balance Sheet

The company has 2.35 million in cash and 387,518 in debt, giving a net cash position of 1.96 million.

Cash & Cash Equivalents	2.35M
Total Debt	387,518
Net Cash	1.96M
Net Cash Per Share	n/a
Equity (Book Value)	2.30M
Book Value Per Share	0.12
Working Capital	1.48M

Cash Flow

Operating Cash Flow	-5.73M
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Oragenics does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-99.08%
Shareholder Yield	-99.08%
Earnings Yield	-490.67%
FCF Yield	n/a

Stock Splits

The last stock split was on January 23, 2023. It was a reverse split with a ratio of 0.0166666667.

Last Split Date	Jan 23, 2023
Split Type	Reverse
Split Ratio	0.0166666667

Scores

Oragenics has an Altman Z-Score of -67.32. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-67.32
Piotroski F-Score	n/a